A comprehensive new review argues that next-generation sequencing has transformed horticultural crop genomics, but ...

Ambry reports positive reclassification in 5% of previously negative or uncertain cases after lab-driven reanalysis; the test includes ongoing review.

How Fast Can Testing Really Be? A Powerful Look at Rapid Precision Oncology / Biocartis Idylla platform, biomarker testing, ...

Mursla Bio, a precision medicine and diagnostics company built on tissue-specific extracellular vesicles (TS-EVs), today announced publication of a peer-reviewed study in the Journal of Extracellular ...

PacBio and AI drug discovery company TychoBio are generating full-length RNA datasets from more than 10,000 samples to train ...

However, the shift to precision oncology involves therapy based more on molecular profiles and the context of an individual ...

Multiomics analysis combines data from two or more omics layers—such as genomics, transcriptomics, proteomics, and ...

Shanghai researchers reviewed how circadian rhythm disruptions may affect tumor immunity and metastasis, and highlighted the ...

Epidemiological studies link light at night (LAN), shift work, chronic jet lag (CJL), and core clock gene mutations to higher cancer risk and aggressive spread, especially in breast and colorectal ...

In the previous article, we covered Nobel Prizes that changed 'how we measure,' such as immunoassays, monoclonal antibodies, ...

Autism spectrum disorder (ASD) is a heritable neurodevelopmental disorder marked by social deficits, repetitive behaviors, ...

Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of the central challenges in genomics: understanding the functional consequences of genetic ...